We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Genetic Link Found for Physical and Psychological Disorders

By LabMedica International staff writers
Posted on 22 Mar 2018
Print article
Image: GWAS results: an illustration of a Manhattan plot depicting several strongly associated risk loci. Each dot represents a SNP, with the X-axis showing genomic location and Y-axis showing association level (Photo courtesy of Wikimedia Commons).
Image: GWAS results: an illustration of a Manhattan plot depicting several strongly associated risk loci. Each dot represents a SNP, with the X-axis showing genomic location and Y-axis showing association level (Photo courtesy of Wikimedia Commons).
Results of a series of genome-wide association studies have indicated that insomnia is at least partially hereditary and that it is linked to physical and psychological disorders such as depression and type II diabetes.

Based on earlier genomic studies that had demonstrated the heritability of insomnia, investigators at the University of California, San Diego (USA) conducted genome-wide association studies (GWAS) on DNA samples obtained from more than 33,000 soldiers participating in the Army Study to Assess Risk and Resilience in Servicemembers (STARRS). For this study, GWAS were carried out separately for each ancestral group (EUR, AFR, LAT).

Results published in the March 8, 2018, online edition of the journal Molecular Psychiatry revealed that heritability (SNP-based) for lifetime insomnia disorder was significant. Genetic contributions to insomnia disorder in STARRS were significantly positively correlated with major depressive disorder and type II diabetes, and negatively with morningness chronotype and subjective wellbeing.

In addition, the study identified a genome-wide significant locus on chromosome seven and a genome-wide significant gene-based association in the EUR group on chromosome nine.

"Several of these variants rest comfortably among locations and pathways already known to be related to sleep and circadian rhythms," said senior author Dr. Murray Stein, professor of psychiatry, family medicine, and public health at the University of California, San Diego. "Such insomnia associated loci may contribute to the genetic risk underlying a range of health conditions including psychiatric disorders and metabolic disease. The genetic correlation between insomnia disorder and other psychiatric disorders, such as major depression, and physical disorders such as type II diabetes suggests a shared genetic diathesis for these commonly co-occurring phenotypes. A better understanding of the molecular bases for insomnia will be critical for the development of new treatments."

Related Links:
University of California, San Diego

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.